CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −563 | $565.69 | $318K | 44,628 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,261 | $566.72 | $715K | 43,367 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,339 | $567.76 | $760K | 42,028 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −728 | $568.78 | $414K | 41,300 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −227 | $569.57 | $129K | 41,073 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −260 | $570.76 | $148K | 40,813 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −300 | $571.55 | $171K | 40,513 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 145,410 | ||
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,479 | $570.81 | $844K | 48,534 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −581 | $571.55 | $332K | 47,953 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $572.45 | $183K | 47,633 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $574.23 | $253K | 47,193 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $575.50 | $391K | 46,513 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,469 | $576.23 | $1.4M | 44,044 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,756 | $577.24 | $1.0M | 42,288 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,695 | $578.22 | $980K | 40,593 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $579.59 | $46K | 40,513 |
| 2026-05-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 154,910 | ||
| 2026-05-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $575.96 | $864K | 43,153 |
Page 94 of 120 · 2,391 trades